Balance Sheet Shenyang Xingqi Pharmaceutical Co.,Ltd.

Stocks

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2026-07-17			5-day change	1st Jan Change
39.63 ^CNY	-7.41%		-2.37%	-18.25%

06-30	Shenyang Xingqi Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	CI
06-28	Shenyang Xingqi Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	CI

96312f80fd0339cb8.sI8xf08lAyOO2PQsWysjlEpaZWWU7R9Aa6IfLfpRBvQ.h-hwFhlLTkvLq5NhPRJq8iE0PSDaj1QlIdRzb88lVqOEywYTHFZAb-G7lw

Published financial data: SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.02B	1.23B	1.44B	1.92B	2.45B
Other Revenues, Total	3.6M	23.2M	27.86M	19.49M	19.92M
Total Revenues	1.03B	1.25B	1.47B	1.94B	2.47B
Cost of Goods Sold, Total	229M	270M	340M	425M	478M
Gross Profit	799M	980M	1.13B	1.52B	1.99B
Selling General & Admin Expenses, Total	457M	595M	690M	876M	939M
Provision for Bad Debts	-187K	926K	3.03M	3.32M	1.08M
R&D Expenses	88.45M	146M	167M	221M	226M
Other Operating Expenses	13.8M	6.66M	7.16M	10.68M	18.92M
Other Operating Expenses, Total	559M	749M	867M	1.11B	1.18B
Operating Income	240M	231M	260M	408M	810M
Interest Expense, Total	-5.99M	-937K	-1.44M	-5.71M	-4.44M
Interest And Investment Income	3.98M	9.93M	7.91M	5.66M	2.25M
Net Interest Expenses	-2.02M	9M	6.48M	-55.24K	-2.18M
Currency Exchange Gains (Loss)	-125K	-89.63K	200K	-109K	-1.67M
Other Non Operating Income (Expenses)	-1.05M	-917K	-1.15M	-2.11M	-1.49M
EBT, Excl. Unusual Items	237M	239M	265M	406M	805M
Gain (Loss) On Sale Of Investments	-	-	-	-24.24K	-
Gain (Loss) On Sale Of Assets	5.16M	421K	-37.53K	-978K	52.54K
Asset Writedown	-1.68K	-4.9K	-	-14.05M	-3.7M
Other Unusual Items	1.26M	-5.88M	-421K	3.94M	-1.22M
EBT, Incl. Unusual Items	244M	234M	265M	395M	800M
Income Tax Expense	34.43M	22.03M	24.96M	56.97M	104M
Earnings From Continuing Operations	209M	212M	240M	338M	696M
Net Income to Company	209M	212M	240M	338M	696M
Minority Interest	-14.41M	-	-	-	-
Net Income - (IS)	195M	212M	240M	338M	696M
Net Income to Common Incl Extra Items	195M	212M	240M	338M	696M
Net Income to Common Excl. Extra Items	195M	212M	240M	338M	696M
Per Share Items
Net EPS - Basic	0.6	0.61	0.68	0.96	1.95
Basic EPS - Continuing Operations	0.6	0.61	0.68	0.96	1.95
Basic Weighted Average Shares Outstanding	324M	349M	353M	354M	357M
Net EPS - Diluted	0.6	0.61	0.68	0.95	1.95
Diluted EPS - Continuing Operations	0.6	0.61	0.68	0.95	1.95
Diluted Weighted Average Shares Outstanding	327M	349M	353M	356M	357M
Normalized Basic EPS	0.41	0.43	0.47	0.72	1.41
Normalized Diluted EPS	0.41	0.43	0.47	0.71	1.41
Dividend Per Share	0.16	0.38	1.3	0.74	1.17
Payout Ratio	24.21	38.19	74.36	138.01	50.45
Supplemental Items
EBITDA	297M	295M	338M	500M	912M
EBITA	241M	232M	261M	415M	820M
EBIT	240M	231M	260M	408M	810M
EBITDAR	299M	296M	339M	501M	913M
Total Revenues (As Reported)	1.03B	1.25B	1.47B	1.94B	2.47B
Effective Tax Rate - (Ratio)	14.14	9.43	9.42	14.42	13.05
Current Domestic Taxes	-	-	-	55.13M	100M
Total Current Taxes	37.03M	27.66M	24.22M	55.13M	100M
Deferred Domestic Taxes	-	-	-	1.84M	4.37M
Total Deferred Taxes	-2.59M	-5.63M	736K	1.84M	4.37M
Normalized Net Income	134M	149M	166M	254M	503M
Interest on Long-Term Debt	11.31M	599K	557K	239K	463K
Supplemental Operating Expense Items
Advertising Expense	5.22M	13M	13.81M	42.52M	-
Marketing Expenses	-	-	-	-	84.71M
Selling and Marketing Expenses	338M	463M	535M	705M	764M
General and Administrative Expenses	118M	132M	154M	170M	175M
Research And Development Expense From Footnotes	88.45M	146M	167M	226M	233M
Net Rental Expense, Total	1.89M	534K	1.38M	1.55M	1.96M
Imputed Operating Lease Interest Expense	947K	64.05K	342K	482K	468K
Imputed Operating Lease Depreciation	943K	470K	1.04M	1.07M	1.49M
Stock-Based Comp., COGS (Total)	-	-	1.68M	857K	514K
Stock-Based Comp., R&D Exp. (Total)	-	-	5.2M	2.72M	606K
Stock-Based Comp., S&M Exp. (Total)	-	-	10.29M	4.77M	2.68M
Stock-Based Comp., G&A Exp. (Total)	13.31M	11.01M	6.25M	3.21M	2.8M
Total Stock-Based Compensation	13.31M	11.01M	23.42M	11.55M	6.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	686M	515M	480M	370M	394M
Total Cash And Short Term Investments	686M	515M	480M	370M	394M
Accounts Receivable, Total	171M	195M	252M	278M	326M
Other Receivables	5.84M	4.62M	3.93M	3.37M	2.09M
Total Receivables	176M	200M	256M	281M	328M
Inventory	92.33M	122M	136M	154M	189M
Other Current Assets, Total	29.27M	27.87M	32.71M	24.9M	19.78M
Total Current Assets	984M	865M	905M	830M	931M
Gross Property Plant And Equipment	892M	1.1B	1.32B	1.51B	1.9B
Accumulated Depreciation	-343M	-403M	-484M	-517M	-603M
Net Property Plant And Equipment	549M	696M	837M	992M	1.3B
Long-term Investments	-	-	-	10M	11.67M
Other Intangibles, Total	22.83M	27.66M	78.29M	135M	223M
Deferred Tax Assets Long-Term	30.45M	23.77M	38.57M	22.5M	19.68M
Deferred Charges Long-Term	60.77M	105M	119M	64.44M	3.4M
Other Long-Term Assets, Total	39.78M	65.39M	45.68M	74M	50.01M
Total Assets	1.69B	1.78B	2.02B	2.13B	2.54B
Liabilities
Accounts Payable, Total	13.31M	19.46M	17.57M	17.73M	35.49M
Accrued Expenses, Total	109M	104M	125M	178M	218M
Short-term Borrowings	100M	-	70.06M	200M	70.05M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	4.18M	7.12M	6.87M	6.28M	7.6M
Current Income Taxes Payable	11.69M	-	5.74M	22.84M	56.3M
Unearned Revenue Current, Total	6.11M	2.01M	6.55M	3.46M	1.88M
Other Current Liabilities	22.63M	19.89M	27.98M	32.67M	111M
Total Current Liabilities	267M	152M	260M	461M	501M
Long-Term Leases	7.1M	6.69M	2.22M	8.86M	4.38M
Unearned Revenue Non Current	68.42M	71.5M	71.58M	64.13M	55.72M
Total Liabilities	342M	231M	334M	534M	561M
Common Stock, Total	88.1M	88.56M	125M	175M	246M
Additional Paid In Capital	783M	852M	891M	867M	830M
Retained Earnings	479M	611M	674M	551M	900M
Treasury Stock	-5.28M	-	-	-	-
Comprehensive Income and Other	-	-	-	-	1.42M
Total Common Equity	1.34B	1.55B	1.69B	1.59B	1.98B
Minority Interest	-	-	-	-	-
Total Equity	1.34B	1.55B	1.69B	1.59B	1.98B
Total Liabilities And Equity	1.69B	1.78B	2.02B	2.13B	2.54B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	351M	352M	354M	356M	357M
ECS Total Common Shares Outstanding	351M	352M	354M	356M	357M
Book Value / Share	3.84	4.41	4.77	4.48	5.54
Tangible Book Value	1.32B	1.52B	1.61B	1.46B	1.76B
Tangible Book Value Per Share	3.77	4.33	4.55	4.1	4.91
Total Debt	111M	13.81M	79.15M	215M	82.03M
Net Debt	-575M	-502M	-401M	-155M	-312M
Debt Equivalent Oper. Leases	15.13M	4.27M	11.07M	12.43M	15.69M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	6	3	6	6	6
Inventories - Raw Materials, Total	48.07M	54.96M	56.27M	68.26M	84.15M
Inventories - Work In Process, Total	21.37M	34.33M	37.89M	19.23M	39.31M
Inventories - Finished Goods, Total	25.12M	33.67M	46.55M	63.07M	60.62M
Inventories - Others	4.78M	8.3M	8.67M	10.05M	13.55M
Buildings, Total	350M	471M	477M	517M	528M
Machinery, Total	481M	534M	712M	760M	965M
Full Time Employees	-	1.76K	2K	2.43K	2.4K
Accumulated Allowance for Doubtful Accounts (Supple)	6.97M	7.89M	10.93M	12.93M	14.01M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	195M	212M	240M	338M	696M
Depreciation & Amortization - CF	66.04M	72.08M	84.89M	92.91M	101M
Amortization of Goodwill and Intangible Assets - (CF)	534K	534K	1.39M	7M	9.15M
Depreciation & Amortization, Total	66.57M	72.61M	86.28M	99.92M	110M
Amortization of Deferred Charges, Total - (CF)	6.92M	7.42M	7.06M	6.58M	5.01M
(Gain) Loss From Sale Of Asset	-5.16M	-421K	37.53K	978K	-52.54K
(Gain) Loss on Sale of Investments - (CF)	-3.14M	-	-	-	-
Asset Writedown & Restructuring Costs	1.68K	4.9K	-	14.05M	3.7M
Provision and Write-off of Bad Debts	-187K	926K	3.03M	3.32M	1.08M
Other Operating Activities, Total	24.49M	5.53M	10.23M	10.54M	19.17M
Change In Accounts Receivable	-33.43M	-37.51M	-104M	-144M	-175M
Change In Inventories	-27.8M	-34.35M	-22.05M	-20.99M	-47.6M
Change In Accounts Payable	73.27M	23.51M	73.17M	95.54M	130M
Change In Deferred Taxes	-2.59M	-5.62M	736K	1.84M	4.37M
Change in Other Net Operating Assets	13.31M	42.47M	23.42M	11.55M	6.6M
Cash from Operations	307M	286M	318M	417M	753M
Capital Expenditure	-95.06M	-299M	-262M	-199M	-271M
Sale of Property, Plant, and Equipment	19.03M	76.76K	21.24K	326K	50K
Divestitures	1.26M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-130M	-	-	-10M	-
Other Investing Activities, Total	3M	-	-	-7.28M	741K
Cash from Investing	-202M	-299M	-262M	-216M	-270M
Short Term Debt Issued, Total	100M	20M	70M	310M	181M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	100M	20M	70M	310M	181M
Short Term Debt Repaid, Total	-80M	-120M	-	-180M	-311M
Long-Term Debt Repaid, Total	-8.7M	-6.17M	-7.67M	-8.93M	-11.66M
Total Debt Repaid	-88.7M	-126M	-7.67M	-189M	-323M
Issuance of Common Stock	580M	27.56M	25.3M	22.17M	19.22M
Repurchase of Common Stock	-272K	-	-	-320K	-22.16M
Common Dividends Paid	-47.13M	-80.84M	-178M	-467M	-351M
Common & Preferred Stock Dividends Paid	-47.13M	-80.84M	-178M	-467M	-351M
Other Financing Activities, Total	-5.95M	1.02M	6.69M	4.87M	37.3M
Cash from Financing	538M	-158M	-84.17M	-319M	-458M
Foreign Exchange Rate Adjustments	-125K	-89.63K	200K	-109K	-1.67M
Net Change in Cash	643M	-171M	-28.34M	-118M	23.59M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	103M	134M	110M	215M	309M
Levered Free Cash Flow	127M	-133M	-20.83M	208M	446M
Unlevered Free Cash Flow	131M	-133M	-19.94M	211M	449M
Change In Net Working Capital	10.91M	68.98M	37.19M	-36.81M	-90.92M
Net Debt Issued / Repaid	11.3M	-106M	62.33M	121M	-142M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	11.32	8.33	8.53	12.3	21.71
Return on Total Capital	13.47	9.56	9.74	14.27	26.19
Return On Equity %	20.52	14.62	14.81	20.59	38.97
Return on Common Equity	19.21	14.62	14.81	20.59	38.97
Margin Analysis
Gross Profit Margin %	77.72	78.39	76.81	78.16	80.67
SG&A Margin	44.41	47.64	47	45.06	37.95
EBITDA Margin %	28.88	23.64	23.02	25.72	36.86
EBITA Margin %	23.43	18.54	17.81	21.38	33.14
EBIT Margin %	23.38	18.5	17.71	21.02	32.77
Income From Continuing Operations Margin %	20.34	16.94	16.36	17.4	28.14
Net Income Margin %	18.94	16.94	16.36	17.4	28.14
Net Avail. For Common Margin %	18.94	16.94	16.36	17.4	28.14
Normalized Net Income Margin	13.02	11.96	11.3	13.06	20.35
Levered Free Cash Flow Margin	12.38	-10.66	-1.42	10.7	18.04
Unlevered Free Cash Flow Margin	12.75	-10.62	-1.36	10.88	18.15
Asset Turnover
Asset Turnover	0.78	0.72	0.77	0.94	1.06
Fixed Assets Turnover	1.91	2.01	1.91	2.12	2.16
Receivables Turnover (Average Receivables)	6.23	6.71	6.44	7.26	8.12
Inventory Turnover (Average Inventory)	2.85	2.52	2.64	2.93	2.79
Short Term Liquidity
Current Ratio	3.69	5.68	3.48	1.8	1.86
Quick Ratio	3.23	4.69	2.83	1.41	1.44
Operating Cash Flow to Current Liabilities	1.15	1.88	1.22	0.9	1.5
Days Sales Outstanding (Average Receivables)	58.59	54.39	56.67	50.42	44.93
Days Outstanding Inventory (Average Inventory)	128.02	145.01	138.5	124.85	130.91
Average Days Payable Outstanding	14.41	19.93	19.08	14.61	18.91
Cash Conversion Cycle (Average Days)	172.2	179.47	176.09	160.65	156.92
Long Term Solvency
Total Debt/Equity	8.28	0.89	4.68	13.51	4.15
Total Debt / Total Capital	7.64	0.88	4.47	11.91	3.98
LT Debt/Equity	0.53	0.43	0.13	0.56	0.22
Long-Term Debt / Total Capital	0.49	0.43	0.13	0.49	0.21
Total Liabilities / Total Assets	20.3	12.94	16.5	25.12	22.09
EBIT / Interest Expense	40.11	246.62	180.77	71.49	182.71
EBITDA / Interest Expense	51.23	324.07	240.77	88.98	207.57
(EBITDA - Capex) / Interest Expense	35.36	4.88	58.59	54.2	146.59
Total Debt / EBITDA	0.36	0.05	0.23	0.42	0.09
Net Debt / EBITDA	-1.87	-1.65	-1.16	-0.3	-0.34
Total Debt / (EBITDA - Capex)	0.53	3.02	0.94	0.7	0.13
Net Debt / (EBITDA - Capex)	-2.71	-109.57	-4.76	-0.5	-0.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	49.26	21.59	17.42	32.42	27.24
Gross Profit, 1 Yr. Growth %	59.52	22.64	15.05	34.74	31.34
EBITDA, 1 Yr. Growth %	88.34	-0.7	13.64	46.88	81.43
EBITA, 1 Yr. Growth %	112.54	-4.07	11.91	57.45	96.08
EBIT, 1 Yr. Growth %	114.37	-3.79	12.43	57.13	98.44
Earnings From Cont. Operations, 1 Yr. Growth %	123.74	1.23	13.39	40.84	105.84
Net Income, 1 Yr. Growth %	121.31	8.72	13.39	40.84	105.84
Normalized Net Income, 1 Yr. Growth %	128.1	11.73	20.23	53	98.24
Diluted EPS Before Extra, 1 Yr. Growth %	120.18	1.25	12.21	39.85	105.08
Accounts Receivable, 1 Yr. Growth %	7.83	14.27	29.31	10.25	17.27
Inventory, 1 Yr. Growth %	35.17	32.43	11.25	12.92	23.19
Net Property, Plant and Equip., 1 Yr. Growth %	3.92	26.86	20.32	18.49	31.11
Total Assets, 1 Yr. Growth %	74.68	5.7	13.51	5.13	19.33
Tangible Book Value, 1 Yr. Growth %	100.75	15.36	5.7	-9.5	20.35
Common Equity, 1 Yr. Growth %	97.09	15.46	8.86	-5.73	24.16
Cash From Operations, 1 Yr. Growth %	151.28	-6.74	10.94	31.3	80.68
Capital Expenditures, 1 Yr. Growth %	-12.11	214.79	-12.45	-24.15	36.14
Levered Free Cash Flow, 1 Yr. Growth %	-1.12K	-204.68	-80.03	-1.02K	115.5
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.59K	-201.24	-80.78	-1.08K	113.16
Dividend Per Share, 1 Yr. Growth %	160.19	130.72	245.33	-43.24	58.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	37.66	34.72	19.49	24.7	29.81
Gross Profit, 2 Yr. CAGR %	42.17	39.87	18.78	24.51	33.03
EBITDA, 2 Yr. CAGR %	95.02	36.92	6.54	29.68	63.66
EBITA, 2 Yr. CAGR %	150.59	43	4.01	33.38	76.25
EBIT, 2 Yr. CAGR %	153.17	43.61	4	32.91	76.58
Earnings From Cont. Operations, 2 Yr. CAGR %	166.19	50.5	7.14	26.37	70.26
Net Income, 2 Yr. CAGR %	132.9	55.12	11.03	26.37	70.26
Normalized Net Income, 2 Yr. CAGR %	123.6	59.64	11.36	35.63	74.16
Diluted EPS Before Extra, 2 Yr. CAGR %	129.86	49.39	6.55	25.34	69.44
Accounts Receivable, 2 Yr. CAGR %	14.39	11	21.56	19.4	13.7
Inventory, 2 Yr. CAGR %	7.52	33.79	21.38	12.08	17.95
Net Property, Plant and Equip., 2 Yr. CAGR %	7.55	14.82	23.55	19.4	24.64
Total Assets, 2 Yr. CAGR %	40.68	35.88	9.53	9.24	12.01
Tangible Book Value, 2 Yr. CAGR %	55.77	52.18	10.43	-2.19	4.37
Common Equity, 2 Yr. CAGR %	53.78	50.85	12.11	1.31	8.19
Cash From Operations, 2 Yr. CAGR %	103.56	53.08	1.71	20.69	54.02
Capital Expenditures, 2 Yr. CAGR %	16.55	66.34	66.01	-18.51	1.62
Levered Free Cash Flow, 2 Yr. CAGR %	260.52	226.33	-59.54	41.16	345.07
Unlevered Free Cash Flow, 2 Yr. CAGR %	222.76	288.21	-61	42.77	355.64
Dividend Per Share, 2 Yr. CAGR %	128.12	145.01	182.27	40	-5.1
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	33.58	32.08	28.68	23.65	25.54
Gross Profit, 3 Yr. CAGR %	37.15	35.34	31.05	23.88	26.75
EBITDA, 3 Yr. CAGR %	85.22	55.85	28.93	18.87	45.29
EBITA, 3 Yr. CAGR %	174.38	82.13	32.12	19.81	51.98
EBIT, 3 Yr. CAGR %	180.68	83.38	32.36	19.34	51.91
Earnings From Cont. Operations, 3 Yr. CAGR %	185.26	92.86	36.95	17.37	48.69
Net Income, 3 Yr. CAGR %	142.47	80.67	39.73	20.19	48.69
Normalized Net Income, 3 Yr. CAGR %	141.57	77.44	41.42	23.8	53.92
Diluted EPS Before Extra, 3 Yr. CAGR %	140.98	74.96	35.76	16.7	47.74
Accounts Receivable, 3 Yr. CAGR %	16.93	14.35	16.8	17.66	18.68
Inventory, 3 Yr. CAGR %	17.92	15.25	25.81	18.49	15.67
Net Property, Plant and Equip., 3 Yr. CAGR %	8.88	13.64	16.62	21.84	23.18
Total Assets, 3 Yr. CAGR %	33.53	27.89	27.97	8.05	12.51
Tangible Book Value, 3 Yr. CAGR %	36.29	40.93	34.77	3.34	4.81
Common Equity, 3 Yr. CAGR %	35.08	39.77	35.31	5.82	8.41
Cash From Operations, 3 Yr. CAGR %	91.06	56.92	37.5	10.75	38.07
Capital Expenditures, 3 Yr. CAGR %	28.04	62.31	34.3	27.86	-3.31
Levered Free Cash Flow, 3 Yr. CAGR %	79.66	138.73	18.52	17.75	62.31
Unlevered Free Cash Flow, 3 Yr. CAGR %	76.41	119.3	31.32	17.29	62.95
Dividend Per Share, 3 Yr. CAGR %	37.54	128.98	174.71	65.37	45.96
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	24.83	28.27	27.76	29.08	29.13
Gross Profit, 5 Yr. CAGR %	25.75	29.92	29.48	30.9	31.84
EBITDA, 5 Yr. CAGR %	25.37	29.32	48.54	44.97	42.05
EBITA, 5 Yr. CAGR %	32.69	38.69	86.25	61.04	48.55
EBIT, 5 Yr. CAGR %	32.98	39.07	88.69	61.23	48.53
Earnings From Cont. Operations, 5 Yr. CAGR %	30.96	40.66	92.81	62.86	49.41
Net Income, 5 Yr. CAGR %	29.11	39.94	77.41	56.6	51.23
Normalized Net Income, 5 Yr. CAGR %	31.96	40.88	77.22	56.82	53.71
Diluted EPS Before Extra, 5 Yr. CAGR %	21.44	37.51	73.9	53.08	48.38
Accounts Receivable, 5 Yr. CAGR %	11.92	14.15	18.76	16.34	15.55
Inventory, 5 Yr. CAGR %	13.93	17.4	19.29	13.97	22.6
Net Property, Plant and Equip., 5 Yr. CAGR %	4.36	10.07	14.52	15.91	19.77
Total Assets, 5 Yr. CAGR %	18.52	21.39	23.36	20.08	21.33
Tangible Book Value, 5 Yr. CAGR %	21.61	23.7	25.29	21.78	21.67
Common Equity, 5 Yr. CAGR %	20.88	23.04	25.37	22.89	23.73
Cash From Operations, 5 Yr. CAGR %	61.29	54.33	48.48	41.28	43.89
Capital Expenditures, 5 Yr. CAGR %	92.24	59.17	42.05	23.21	20.13
Levered Free Cash Flow, 5 Yr. CAGR %	151.88	115.45	-1.04	84.23	104.36
Unlevered Free Cash Flow, 5 Yr. CAGR %	108.34	166.34	-3.54	75.83	119.53
Dividend Per Share, 5 Yr. CAGR %	39.08	43.11	83.37	88.08	79.57